Safety of Disease Modifying Antirheumatic Drug (DMARD) and Biologic Treatment of Rheumatoid Arthritis.
Phase of Trial: Phase IV
Latest Information Update: 17 Jun 2017
At a glance
- Drugs Abatacept (Primary) ; Disease-modifying antirheumatics; Tumour necrosis factor inhibitors
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Acronyms RALLY
- Sponsors Bristol-Myers Squibb
- 17 Jun 2017 Results presented at the 18th Annual Congress of the European League Against Rheumatism
- 07 Dec 2016 Status changed from active, no longer recruiting to completed.
- 13 Jun 2015 Preliminary safety results presented at the 16th Annual Congress of the European League Against Rheumatism.